Novel p53/p130 Axis in Bladder Tumors

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Objectives: To identify the relationships between key components of the proliferative and apoptotic pathways in bladder tumors. Methods: A tissue array of 88 bladder tumors was assembled. Immunohistochemical analyses were used to investigate the relationship between nine different parameters: stage, proliferation (Ki67), apoptosis (in situ DNA nick end labeling), the anti-apoptotic protein Bcl-2, tumor suppressors p53 and retinoblastoma protein (Rb), the Rb-related protein p130, cyclin E, and the cyclin-dependent kinase inhibitor p27. The protein expression in each tumor was reported as the percentage of positively staining cells. Results: The analysis focused on Stage 1 to 3 tumors. Analysis found that p53 expression increased progressively with stage, and Rb and p27 decreased with increasing stage. Overall, the cyclin E levels correlated with the proliferative index. Cyclin E levels were low in Stage 1 tumors and elevated in Stage 2 tumors, but were decreased in Stage 3 tumors. Multivariate analysis uncovered a correlation between cyclin E and proliferation (Ki67) and a weak correlation between p53 and Bcl-2 and between p27 and Rb. A strong correlation was found between the expression of p53 and p130, which was apparent in Stages 1 and 3, but not in Stage 2. Furthermore, high levels of p130 protein were detected primarily in the cytoplasm. Conclusions: These results suggest a novel p53/p130 axis in bladder tumors.

Original languageEnglish (US)
Pages (from-to)608-612
Number of pages5
Issue number3
StatePublished - Sep 2007

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'Novel p53/p130 Axis in Bladder Tumors'. Together they form a unique fingerprint.

Cite this